2,246 press releases in English indexed under biotech & pharma.
HRSA review finds 4 out of 5 drugmakers out of compliance with mandatory discount drug pricing WASHINGTON, October 19, 2026--In response to news in the 340B Report last week that was highly critical of the drug industry's noncompliance with compulsory elements of the 340B drug pricing program, AIDS Hea
According to The Insight Partners, the Live Vaccines Market size is expected to reach US$ 41.14 billion by 2034 from US$ 18.31 billion in 2025, registering a CAGR of 9.41% during 2026–2034. The global Live Vaccines Market is experiencing significant ... Read more
Boost ROI through platform standardization, AI-ready automation, early quality assessment, scalable workflows and strategic CDMO partnerships that cut rework and speed development Boost ROI through platform standardization, AI-ready automation, early quality assessment, scalable workflows and strategic CDMO partnerships that cut rework and speed development
The Global Vaccines Market is experiencing steady growth, driven by increasing immunization initiatives, rising awareness of preventable diseases, and continued investment in vaccine research and development. Vaccines play a critical role in preventing infectious diseases, reducing healthcare burdens, and supporting ... Read more
The global aquaculture vaccines market is experiencing notable growth, supported by increasing demand for effective disease prevention solutions in aquaculture. The market size is projected to reach US$ 0.82 billion by 2031, increasing from US$ 0.31 billion in 2023. This ... Read more
Building on Omvoh's approved use and durable efficacy in adults, Lilly plans to submit these data to global regulators to support a potential label...
Dr. Weber, an otologist and neurotologist who led the clinical development of the first FDA-approved gene therapy for genetic hearing loss, joins as SENS-601 advances into the clinic MONTPELLIER, France & CAMBRIDGE, Mass., October 19, 2026--Regulatory News: Sensorion (FR001401A9Z0 – ALSEN) ("the Compan
In a Phase 2a study, ABBV-466 achieved higher endoscopic remission rates in patients with Crohn's disease than either anti-IL-23 p19 or anti-α4β7...
New York, New York--(October 19, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Unicycive Therapeutics, Inc. ("Unicycive" or the "Company") (NASDAQ: UNCY) on behalf of investors that purchased or otherwise acquired Unicycive securities between December 29, 2025 and June 29, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Unicycive and have suffered losses, you may CLICK HERE to contact us. You may...
Montreal, Quebec--(October 19, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® drug-delivery platform, is pleased to announce two significant achievements at World ADC San Diego 2026, held October 12-15: winning the conference's Best Poster Award for its Accum®-ADC research and leading a main-stage...